EdgeMarketInstruments › ATYR

ATYR — aTYR PHARMA INC

US Healthcare Pharma & biotech equity mkt cap 49.2M
0.50 -0.30% today
USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown
52w low 0.40 · high 6.03

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.

Performance

1 day-0.30%
1 week-10.29%
1 month+0.68%
3 months-5.11%
6 months-51.78%
Year to date-33.93%
1 year-89.81%
3 years-74.02%
5 years-89.62%

Technicals

RSI 1452.0
vs 50-day avg-3.57%
vs 200-day avg-29.16%
Volatility 1y137.3%
Max drawdown 1y-93.43%
Avg volume 30d927.8K
Daily bars held2,674
History from2016-01-04

Measured signals that fired on ATYR

datesignal measured base rate
2026-05-15Institutional holders jumped in a quarter
ownership
-0.52% over 21 days · t = -0.38 · n = 1,553
not distinguishable from its control group

Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →

Insider transactions (Form 4)

dateinsiderwhatshares pricevalue
2026-05-27SCHIMMEL PAUL
Director
Open-market purchase100.0K0.5049.6K
2026-02-04Shukla Sanjay
President and CEO
Open-market sale3.7K0.983.7K
2026-02-04Broadfoot Jill Marie
Chief Financial Officer
Open-market sale1.6K0.981.5K
2026-02-04DENYES NANCY
General Counsel
Open-market sale1.1K0.981.1K
2026-02-03DENYES NANCY
General Counsel
Option exercise2.7K
2026-02-03Shukla Sanjay
President and CEO
Option exercise10.4K
2026-02-03Broadfoot Jill Marie
Chief Financial Officer
Option exercise3.8K
2025-10-09SCHIMMEL PAUL
Director
Open-market purchase318.0K0.94298.9K
2025-10-08SCHIMMEL PAUL
Director
Open-market purchase682.0K0.90613.8K
2025-03-17Gross Jane A
Director
Open-market purchase3.8K4.0015.0K

Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →

Largest institutional holders

managervalueshares
FMR LLC11.5M14.7M
FEDERATED HERMES, INC.8.2M10.5M
BlackRock, Inc.5.0M6.4M
UBS Group AG3.0M3.9M
VANGUARD CAPITAL MANAGEMENT LLC3.0M3.8M
GEODE CAPITAL MANAGEMENT, LLC1.9M2.4M
STATE STREET CORP1.4M1.8M
MILLENNIUM MANAGEMENT LLC1.3M1.6M
MORGAN STANLEY955.9K1.2M
TWO SIGMA INVESTMENTS, LP892.8K1.1M

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Latest SEC filings

formfiledperiod
S-82026-08-07on EDGAR ↗
10-Q2026-08-072026-06-30on EDGAR ↗
8-K2026-08-072026-08-07on EDGAR ↗
SCHEDULE 13G/A2026-08-06on EDGAR ↗
8-K2026-07-312026-07-30on EDGAR ↗
SCHEDULE 13G/A2026-07-27on EDGAR ↗
SCHEDULE 13G/A2026-07-08on EDGAR ↗
8-K2026-06-082026-06-03on EDGAR ↗

Short selling

Avg short volume, 90d34.4% of tape
Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Ask the AI about ATYR

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open ATYR in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →